The paternally inherited insulin gene B allele (1,428 FokI site) confers protection from insulin-dependent diabetes in families.
Several polymorphisms of the insulin gene and its flanking regions (INS region) are in linkage disequilibrium and confer susceptibility to insulin-dependent diabetes (IDDM). We have analysed INS AA and AB-BB genotypes at the 1,428 FokI site (3' of the insulin gene) in 217 patients with IDDM, 402 non-diabetic first degree relatives negative for insulin (IAA) and islet cell autoantibodies (ICA), and 116 autoantibody positive (for ICA or IAA, or both) relatives of whom 39 became diabetic on follow-up. Most IDDM patients (83.4%, 181/217) had the AA genotype vs. 50% (25/50) of the controls (P < 10(-6)). Only 16.6% (36/217) of IDDM patients carried the AB genotype and none was BB homozygous, suggesting a protective effect of the B allele. By segregation analysis of the B allele in the IDDM offspring of informative families (only one AB parent) from the United States, the maternal B allele was inherited by 19/35 (54.2%) of the IDDM offspring. In contrast, only 4/26 (15.3%) of the IDDM offspring inherited the paternal B allele (P = 0.001), suggesting maternal imprinting of the INS region. Therefore, the INS B allele may be protective only when paternally inherited. Among the 39 of 116 autoantibody positive relatives who developed IDDM on follow-up, only five of them had the B allele. The frequency of the B allele in this group was much lower (12.8%, 5/39) than that observed in non-diabetic autoantibody positive relatives (32.5%, 25/77, P = 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262.
A
A
Pugliese
Z L
ZL
Awdeh
C A
CA
Alper
R A
RA
Jackson
G S
GS
Eisenbarth
D000328:Adult; D000483:Alleles; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D001327:Autoimmune Diseases / Q000453:epidemiology / Q000235:genetics*; D015252:Deoxyribonucleases, Type II Site-Specific; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000235:genetics*; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D018392:Genomic Imprinting; D006801:Humans; D007328:Insulin / Q000235:genetics* / Q000276:immunology; D007515:Islets of Langerhans / Q000276:immunology; D015810:Linkage Disequilibrium; D008297:Male; D009679:Nuclear Family; D010290:Parents; D012150:Polymorphism, Restriction Fragment Length; D011236:Prediabetic State / Q000453:epidemiology / Q000235:genetics; D012306:Risk; D014481:United States / Q000453:epidemiology
D001323:Autoantibodies; D007328:Insulin; C035042:endodeoxyribonuclease FokI; D015252:Deoxyribonucleases, Type II Site-Specific